
Tarsier Pharma IPO Closing Market Cap
核心摘要
根据「Tarsier Pharma IPO Closing Market Cap」的最新预测市场数据,交易者已形成强烈共识。
目前,<$250M 以压倒性的 5,000% 获胜概率主导市场;$250M-$300M 以 5,000% 位居第二,$300M-$350M 以 5,000% 排名第三。该市场的下注量已达 —,反映出市场的高度关注。
竞争梯队拆解
为了更好地评估各潜在结果的位置,可依据隐含概率与合约定价将市场划分为三个明显的交易梯队:
🥇 第一梯队:绝对领跑者
- <$250M (5,000%):<$250M 目前拥有最高概率,深受订单簿青睐。看好该结果的交易者面对的「Buy Yes」合约价为 5,000¢,显示出市场的高度确信。
🥈 第二梯队:主要挑战者
- $250M-$300M (5,000%):作为最可行的替代选项,$250M-$300M 保持着 5,000% 的成真概率,其「Buy Yes」份额目前成交价为 5,000¢。
- $300M-$350M (5,000%):以 5,000% 的概率位列第三,市场对 $300M-$350M 持谨慎怀疑态度,除非势头转变,否则视其为外围黑马。
🥉 第三梯队:长尾选项(合计约 0%)
在前三名之外,还有大量宏观变量与冷门结果被持续追踪。尽管单个概率偏低,但它们是投机交易者的重要对冲:
- 替代选项:包括 $350M-$400M (5,000%)、$400M-$450M (5,000%),以及 >$450M (5,000%)。
- 投机成交:尽管统计概率偏低,像 No IPO before September 2026 这类长尾合约仍吸引着可观的关注。
完整订单簿与定价面板
下表列出了该预测池中所有结果的合约价格、概率与市场深度的完整拆解:
| 排名 | 预测结果 | 获胜概率 | 成交量 | 买入 Yes(成本) | 买入 No(成本) |
|---|---|---|---|---|---|
| 1 | <$250M | 5000.0% | — | 5000¢ | -4900¢ |
| 2 | $250M-$300M | 5000.0% | — | 5000¢ | -4900¢ |
| 3 | $300M-$350M | 5000.0% | — | 5000¢ | -4900¢ |
| 4 | $350M-$400M | 5000.0% | — | 5000¢ | -4900¢ |
| 5 | $400M-$450M | 5000.0% | — | 5000¢ | -4900¢ |
| 6 | >$450M | 5000.0% | — | 5000¢ | -4900¢ |
| 7 | No IPO before September 2026 | 5000.0% | — | 5000¢ | -4900¢ |
裁决规则
This market will resolve based on Tarsier Pharma's market capitalization at the closing price on its first day of trading.
As of market creation, the IPO is scheduled to price on July 9 (ET). If no such IPO occurs by August 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before September 2026".
Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency.
It is calculated as the total number of outstanding shares, multiplied by the official closing share price of the publicly traded class on the first trading day.
If necessary, to accurately capture the company’s total market capitalization, rather than a stock-class-specific market capitalization, the calculation will include all outstanding share classes and apply any stated conversion ratios to the publicly traded class. Where no conversion right exists, such shares will be counted at their stated outstanding amount without discount, unless official filings explicitly specify differently.
The number of outstanding shares will be determined from official company filings or disclosures (e.g., SEC filings). The closing share price on the first trading day will be determined from the primary exchange’s official listing page.
If the relevant value falls exactly between two brackets, this market will resolve to the higher range bracket.
The primary resolution source for this market will be official company filings and the primary exchange’s official listing page. The market capitalization will be determined through appropriate calculation using the total outstanding shares and the closing price from the first day of trading.
In the event of an interruption in the normal trading session on the specified company’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that day as the first day of trading for the purposes of this market.
常见问题
当前市场对「Tarsier Pharma IPO Closing Market Cap」的共识是什么?
截至最新更新,<$250M 以 5,000% 的获胜概率领跑,其次是 $250M-$300M(5,000%),以及 $300M-$350M(5,000%)。该市场总成交量已达 —,显示出充足的流动性与高交易参与度。
